Human Papillomavirus Vaccine Sources of Information and Adolescents' Knowledge and Perceptions

Brittany L Rosen, Marcia L Shew, Gregory D Zimet, Lili Ding, Tanya L K Mullins, Jessica A Kahn, Brittany L Rosen, Marcia L Shew, Gregory D Zimet, Lili Ding, Tanya L K Mullins, Jessica A Kahn

Abstract

Understanding where adolescents obtain information about human papillomavirus (HPV) vaccines may be helpful in designing public health interventions promoting HPV vaccination. This study assessed the following: (1) exposure to specific sources of information about HPV vaccines, (2) self-reported helpfulness of these sources of information, and (3) whether the specific source of information was associated with knowledge and perceptions about HPV vaccines among adolescent girls. There were 339 adolescent girls (mean age = 16.8 years) recruited into the study. Television advertisements, the Internet, doctors/nurses, and mothers were the most frequently reported sources of vaccine information; more than 90% of participants who received information from these sources reported they were helpful. Adolescents who received information about HPV vaccines from television advertisements, the Internet, clinicians, and mothers had higher knowledge about HPV vaccines and more positive perceptions. Assuring the accuracy of messages from these sources will be essential, given their importance in influencing adolescents' knowledge and perceptions about HPV vaccines.

Keywords: adolescents; human papillomavirus vaccine; information; knowledge; perceptions.

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Dr. Kahn served as the chair of a grant review committee for a grant program sponsored by the Society for Adolescent Health and Medicine, which provided funding for public health demonstration projects to improve adolescent vaccination. Funding for the grant program was provided by Merck. Dr. Kahn has also served as cochair of two clinical trials of an HPV vaccine in HIV-infected individuals; these studies were funded primarily by the National Institutes of Health, but Merck provided vaccines and immunogenicity testing. Dr. Zimet has received funding for investigator-initiated HPV-related research from Merck and from Roche Diagnostics. Dr. Shew has and is currently participating as an investigator for Merck and Co, Inc, related HPV vaccine trials. She has received salary support for her efforts.

References

    1. Petrosky E, Bocchini JA, Jr, Hariri S, et al. ; Centers for Disease Control and Prevention (CDC). Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2015;64:300-304.
    1. Luxembourg A, Moreira ED, Jr, Samakoses R, et al. Phase III, randomized controlled trial in girls 9-15 years old to evaluate lot consistency of a novel nine-valent human papillomavirus L1 virus-like particle vaccine. Hum Vaccin Immunother. 2015;11:1306-1312.
    1. Office of Disease Prevention and Health Promotion. Immunization and infectious diseases. . Accessed November 3, 2017.
    1. de Visser R, Waites L, Parikh C, Lawrie A. The importance of social norms for uptake of catch-up human papillomavirus vaccination in young women. Sex Health. 2011;8:330-337.
    1. Ogilvie G, Anderson M, Marra F, et al. A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: parental factors associated with HPV vaccine receipt. PLoS Med. 2010;7:e1000270.
    1. Fernández ME, Allen JD, Mistry R, Kahn JA. Integrating clinical, community, and policy perspectives on human papillomavirus vaccination. Annu Rev Public Health. 2010;31:235-252.
    1. Conroy K, Rosenthal SL, Zimet GD, et al. Human papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination J Womens Health (Larchmt). 2009;18:1679-1686.
    1. Gerend MA, Lee SC, Shepherd JE. Predictors of human papillomavirus vaccination acceptability among underserved women. Sex Transm Dis. 2007;34:468-471.
    1. Boehner CW, Howe SR, Bernstein DI, Rosenthal SL. Viral sexually transmitted disease vaccine acceptability among college students. Sex Transm Dis. 2003;30:774-778.
    1. Dempsey AF, Abraham LM, Dalton V, Ruffin M. Understanding the reasons why mothers do or do not have their adolescent daughters vaccinated against human papillomavirus. Ann Epidemiol. 2009;19:531-538.
    1. Gerend MA, Weibley E, Bland H. Parental response to human papillomavirus vaccine availability: uptake and intentions. J Adolesc Health. 2009;45:528-531.
    1. Kahn JA, Ding L, Huang B, Zimet GD, Rosenthal SL, Frazier AL. Mothers’ intention for their daughters and themselves to receive the human papillomavirus vaccine: a national study of nurses. Pediatrics. 2009;123:1439-1445.
    1. Reiter PL, Brewer NT, Gottlieb SL, McRee AL, Smith JS. Parents’ health beliefs and HPV vaccination of their adolescent daughters. Soc Sci Med. 2009;69:475-480.
    1. Rogers EM. Diffusion of prevention innovations. Addict Behav. 2002;27:989-993.
    1. Rogers EM. Diffusion of Innovations. 5th ed. New York, NY: Free Press; 2003.
    1. Bero LA, Grilli R, Grimshaw JM, Harvey E, Oxman AD, Thomson MA. Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. The Cochrane Effective Practice and Organization of Care Review Group. BMJ. 1998;317:465-468.
    1. Thompson GN, Estabrooks CA, Degner LF. Clarifying the concepts in knowledge transfer: a literature review. J Adv Nurs. 2006;53:691-701.
    1. Herbert NL, Gargano LM, Painter JE, et al. Understanding reasons for participating in a school-based influenza vaccination program and decision-making dynamics among adolescents and parents. Health Educ Res. 2013;28:663-672.
    1. Wetzel C, Tissot A, Kollar LM, Hillard PA, Stone R, Kahn JA. Development of an HPV educational protocol for adolescents. J Pediatr Adolesc Gynecol. 2007;20:281-287.
    1. Conroy K, Rosenthal SL, Zimet GD, Jin Y, Bernstein DI, Kahn JA. Human papillomavirus vaccine uptake, barriers to vaccination, and predictors of vaccination in young women. J Adolesc Health. 2009;44:S13.
    1. Mullins TL, Zimet GD, Rosenthal SL, et al. Adolescent perceptions of risk and need for safer sexual behaviors after first human papillomavirus vaccination. Arch Pediatr Adolesc Med. 2012;166:82-88.
    1. Hackett AJ. Risk, its perception and the media: the MMR controversy. Community Pract. 2008;81:22-25.
    1. Marlow LA, Zimet GD, McCaffery KJ, Ostini R, Waller J. Knowledge of human papillomavirus (HPV) and HPV vaccination: an international comparison. Vaccine. 2013;31:763-769.
    1. Hughes J, Cates JR, Liddon N, Smith JS, Gottlieb SL, Brewer NT. Disparities in how parents are learning about the human papillomavirus vaccine. Cancer Epidemiol Biomarkers Prev. 2009;18:363-372.
    1. Verhoeven V, Baay MF, Baay PE, Lardon F, Van Royen P, Vermorken JB. Everything you always wanted to know about HPV (but could not ask your doctor). Patient Educ Couns. 2010;81:101-105.
    1. Betsch C, Renkewitz F, Betsch T, Ulshöfer C. The influence of vaccine-critical websites on perceiving vaccination risks. J Health Psychol. 2010;15:446-455.
    1. Nan X, Madden K. HPV vaccine information in the blogosphere: how positive and negative blogs influence vaccine-related risk perceptions, attitudes, and behavioral intentions. Health Commun. 2012;27:829-836.
    1. Kalichman SC, Kegler C. Vaccine-related internet search activity predicts H1N1 and HPV vaccine coverage: implications for vaccine acceptance. J Health Commun. 2015;20:259-265.
    1. Almeida CM, Tiro JA, Rodriguez MA, Diamant AL. Evaluating associations between sources of information, knowledge of the human papillomavirus, and human papillomavirus vaccine uptake for adult women in California. Vaccine. 2012;30:3003-3008.
    1. Kelly BJ, Leader AE, Mittermaier DJ, Hornik RC, Cappella JN. The HPV vaccine and the media: how has the topic been covered and what are the effects on knowledge about the virus and cervical cancer? Patient Educ Couns. 2009;77:308-313.
    1. Bodemer N, Müller SM, Okan Y, Garcia-Retamero R, Neumeyer-Gromen A. Do the media provide transparent health information? A cross-cultural comparison of public information about the HPV vaccine. Vaccine. 2012;30:3747-3756.
    1. Briones R, Nan X, Madden K, Waks L. When vaccines go viral: an analysis of HPV vaccine coverage on YouTube. Health Commun. 2012;27:478-485.
    1. Habel MA, Liddon N, Stryker JE. The HPV vaccine: a content analysis of online news stories. J Womens Health (Larchmt). 2009;18:401-407.
    1. Hull PC, Williams EA, Khabele D, Dean C, Bond B, Sanderson M. HPV vaccine use among African American girls: qualitative formative research using a participatory social marketing approach. Gynecol Oncol. 2014;132(suppl 1):S13-S20.
    1. Mathur MB, Mathur VS, Reichling DB. Participation in the decision to become vaccinated against human papillomavirus by California high school girls and the predictors of vaccine status. J Pediatr Health Care. 2010;24:14-24.
    1. Holman DM, Benard V, Roland KB, Watson M, Liddon N, Stokley S. Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatr. 2014;168:76-82.
    1. Allison MA, Hurley LP, Markowitz L, et al. Primary care physicians’ perspective about HPV vaccine. Pediatrics. 2016;137:e20152488.
    1. Zimet GD. Health care professionals and adolescent vaccination. A call for intervention research. Hum Vaccin Immunother. 2014;10:2629-2630.
    1. Quinn GP, Murphy D, Malo TL, Christie J, Vadaparampil ST. A national survey about human papillomavirus vaccination: what we didn’t ask, but physicians wanted us to know. J Pediatr Adolesc Gynecol. 2012;25:254-258.
    1. Daley MF, Crane LA, Markowitz LE, et al. Human papillomavirus vaccination practices: a survey of US physicians 18 months after licensure. Pediatrics. 2010;126: 425-433.
    1. McCave EL. Influential factors in HPV vaccination uptake among providers in four states. J Community Health. 2010;35:645-652.
    1. Perkins RB, Clark JA. Providers’ attitudes toward human papillomavirus vaccination in young men: challenges for implementation of 2011 recommendations. Am J Mens Health. 2012;6:320-323.
    1. Vadaparampil ST, Murphy D, Rodriguez M, Malo TL, Quinn GP. Qualitative responses to a national physician survey on HPV vaccination. Vaccine. 2013;31:2267-2272.
    1. Perkins RB, Clark JA. What affects human papillomavirus vaccination rates? A qualitative analysis of providers’ perceptions. Womens Health Issues. 2012;22:e379-e386.
    1. Hamlish T, Clarke L, Alexander KA. Barriers to HPV immunization for African American adolescent females. Vaccine. 2012;30:6472-6476.
    1. McRee AL, Reiter PL, Gottlieb SL, Brewer NT. Mother-daughter communication about HPV vaccine. J Adolesc Health. 2011;48:314-317.
    1. Guilamo-Ramos V, Jaccard J, Dittus P, Bouris AM. Parental expertise, trustworthiness, and accessibility: parent-adolescent communication and adolescent risk behavior. J Marriage Fam. 2006;68:1229-1246.
    1. Sherris J, Friedman A, Wittet S, Davies P, Steben M, Saraiya M. Chapter 25: education, training, and communication for HPV vaccines. Vaccine. 2006;24(suppl 3):S3/210-S18.
    1. Askelson NM, Campo S, Smith S, Lowe JB, Dennis LK, Andsager J. The birds, the bees, and the HPVs: what drives mothers’ intentions to use the HPV vaccination as a chance to talk about sex? J Pediatr Health Care. 2011;25:162-170.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다